Computational Structure Based Drug Discovery

We are seeking new orthosteric and allosteric molecules for different GPCRs targets using our in-house structures and computational resources.

  • New allosteric molecules can modulate the activities of the orthosteric ligands without themselves signaling.
  • New orthosteric ligands with novel scaffolds can confer new biology, showing different signaling properties, biased and selective ligands.